Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
A multistage malaria vaccine targeting the pre-erythrocytic and sexual stages of Plasmodium could effectively protect individuals against infection from mosquito bites and provide transmission-blocking (TB) activity against the sexual stages of the parasite, respectively. This strategy could help pr...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Society for Microbiology
2014
|
| _version_ | 1797070401391558656 |
|---|---|
| author | Mizutani, M Iyori, M Blagborough, A Fukumoto, S Funatsu, T Sinden, R Yoshida, S |
| author_facet | Mizutani, M Iyori, M Blagborough, A Fukumoto, S Funatsu, T Sinden, R Yoshida, S |
| author_sort | Mizutani, M |
| collection | OXFORD |
| description | A multistage malaria vaccine targeting the pre-erythrocytic and sexual stages of Plasmodium could effectively protect individuals against infection from mosquito bites and provide transmission-blocking (TB) activity against the sexual stages of the parasite, respectively. This strategy could help prevent malaria infections in individuals and, on a larger scale, prevent malaria transmission in communities of endemicity. Here, we describe the development of a multistage Plasmodium vivax vaccine which simultaneously expresses P. vivax circumsporozoite protein (PvCSP) and P25 (Pvs25) protein of this species as a fusion protein, thereby acting as a pre-erythrocytic vaccine and a TB vaccine, respectively. A new-concept vaccine platform based on the baculovirus dual-expression system (BDES) was evaluated. The BDES-Pvs25-PvCSP vaccine displayed correct folding of the Pvs25-PvCSP fusion protein on the viral envelope and was highly expressed upon transduction of mammalian cells in vitro. This vaccine induced high levels of antibodies to Pvs25 and PvCSP and elicited protective (43%) and TB (82%) efficacies against transgenic P. berghei parasites expressing the corresponding P. vivax antigens in mice. Our data indicate that our BDES, which functions as both a subunit and DNA vaccine, can offer a promising multistage vaccine capable of delivering a potent antimalarial pre-erythrocytic and TB response via a single immunization regimen. |
| first_indexed | 2024-03-06T22:38:17Z |
| format | Journal article |
| id | oxford-uuid:5aabf7f1-076c-4a2d-b507-992e695ea73a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:38:17Z |
| publishDate | 2014 |
| publisher | American Society for Microbiology |
| record_format | dspace |
| spelling | oxford-uuid:5aabf7f1-076c-4a2d-b507-992e695ea73a2022-03-26T17:17:11ZBaculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5aabf7f1-076c-4a2d-b507-992e695ea73aEnglishSymplectic Elements at OxfordAmerican Society for Microbiology2014Mizutani, MIyori, MBlagborough, AFukumoto, SFunatsu, TSinden, RYoshida, SA multistage malaria vaccine targeting the pre-erythrocytic and sexual stages of Plasmodium could effectively protect individuals against infection from mosquito bites and provide transmission-blocking (TB) activity against the sexual stages of the parasite, respectively. This strategy could help prevent malaria infections in individuals and, on a larger scale, prevent malaria transmission in communities of endemicity. Here, we describe the development of a multistage Plasmodium vivax vaccine which simultaneously expresses P. vivax circumsporozoite protein (PvCSP) and P25 (Pvs25) protein of this species as a fusion protein, thereby acting as a pre-erythrocytic vaccine and a TB vaccine, respectively. A new-concept vaccine platform based on the baculovirus dual-expression system (BDES) was evaluated. The BDES-Pvs25-PvCSP vaccine displayed correct folding of the Pvs25-PvCSP fusion protein on the viral envelope and was highly expressed upon transduction of mammalian cells in vitro. This vaccine induced high levels of antibodies to Pvs25 and PvCSP and elicited protective (43%) and TB (82%) efficacies against transgenic P. berghei parasites expressing the corresponding P. vivax antigens in mice. Our data indicate that our BDES, which functions as both a subunit and DNA vaccine, can offer a promising multistage vaccine capable of delivering a potent antimalarial pre-erythrocytic and TB response via a single immunization regimen. |
| spellingShingle | Mizutani, M Iyori, M Blagborough, A Fukumoto, S Funatsu, T Sinden, R Yoshida, S Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. |
| title | Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. |
| title_full | Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. |
| title_fullStr | Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. |
| title_full_unstemmed | Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. |
| title_short | Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. |
| title_sort | baculovirus vectored multistage plasmodium vivax vaccine induces both protective and transmission blocking immunities against transgenic rodent malaria parasites |
| work_keys_str_mv | AT mizutanim baculovirusvectoredmultistageplasmodiumvivaxvaccineinducesbothprotectiveandtransmissionblockingimmunitiesagainsttransgenicrodentmalariaparasites AT iyorim baculovirusvectoredmultistageplasmodiumvivaxvaccineinducesbothprotectiveandtransmissionblockingimmunitiesagainsttransgenicrodentmalariaparasites AT blagborougha baculovirusvectoredmultistageplasmodiumvivaxvaccineinducesbothprotectiveandtransmissionblockingimmunitiesagainsttransgenicrodentmalariaparasites AT fukumotos baculovirusvectoredmultistageplasmodiumvivaxvaccineinducesbothprotectiveandtransmissionblockingimmunitiesagainsttransgenicrodentmalariaparasites AT funatsut baculovirusvectoredmultistageplasmodiumvivaxvaccineinducesbothprotectiveandtransmissionblockingimmunitiesagainsttransgenicrodentmalariaparasites AT sindenr baculovirusvectoredmultistageplasmodiumvivaxvaccineinducesbothprotectiveandtransmissionblockingimmunitiesagainsttransgenicrodentmalariaparasites AT yoshidas baculovirusvectoredmultistageplasmodiumvivaxvaccineinducesbothprotectiveandtransmissionblockingimmunitiesagainsttransgenicrodentmalariaparasites |